Regulus Therapeutics Inc (DELISTED) (RGLS:DL)
8.16
0.00 (0.00%)
USD |
NASDAQ |
Jun 30, 16:00
Regulus Therapeutics Enterprise Value: 499.59M for June 30, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 41.34B |
| SpringWorks Therapeutics Inc (DELISTED) | 3.252B |
| CorMedix, Inc. | 482.86M |
| BioCardia, Inc. | 10.21M |
| Xeris Biopharma Holdings, Inc. | 1.414B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.634M |
| Total Expenses (Quarterly) | 9.634M |
| EPS Diluted (Quarterly) | -0.1456 |
| Earnings Yield | -8.95% |
| Normalized Earnings Yield | -67.40 |